Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2012 Sep 11:12:49.
doi: 10.1186/1471-2415-12-49.

Role of heat shock protein 47 in transdifferentiation of human tenon's fibroblasts to myofibroblasts

Affiliations
Comparative Study

Role of heat shock protein 47 in transdifferentiation of human tenon's fibroblasts to myofibroblasts

Samin Hong et al. BMC Ophthalmol. .

Abstract

Background: Heat shock protein 47 (Hsp47) is a well-known molecular chaperone in collagen synthesis and maturation. The aim of this study is to investigate its putative role in the transdifferentiation of Tenon's fibroblasts to myofibroblasts.

Methods: Primary cultured human Tenon's fibroblasts were exposed to transforming growth factor-β1 (TGF-β1) for up to 48 hours. The mRNA levels of Hsp47 and α smooth muscle actin (αSMA) were determined by quantitative real time RT-PCR. After delivery of small interfering RNA (siRNA) molecules targeting Hsp47 into the cells, the expression of Hsp47 and αSMA proteins was determined by western immunoblotting.

Results: TGF-β1 increased the mRNA expressions of both Hsp47 and αSMA in human Tenon's fibroblasts, as determined by quantitative real time RT-PCR. However, it induced the protein expression of only αSMA but not Hsp47, as determined by western immunoblots. When siRNAs specific for Hsp47 were introduced into those cells, the TGF-β1-induced expression of αSMA was significantly attenuated on western immunoblots; after 48 hours of exposure to TGF-β1, the relative densities of immunobands were 11.58 for the TGF-β1 only group and 2.75 for the siRNA treatment group, compared with the no treatment control group (p < 0.001).

Conclusions: Our data suggest that Hsp47 may be related to the TGF-β1-induced transdifferentiation of human Tenon's fibroblasts to myofibroblasts.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Quantitative real time RT-PCR for heat shock protein 47 (Hsp47) and α smooth muscle actin (αSMA) after exposure to transforming growth factor-β1 (TGF-β1) for up to 48 hours. The level of target mRNA was calculated using a relative ratio to β-actin of no treatment control and expressed as the mean ± S.E.M. (n = 16 for each group).
Figure 2
Figure 2
Representative sequential bands of western immunoblots (A) and densitometric data (B) for heat shock protein 47 (Hsp47), α smooth muscle actin (αSMA), and β-actin. Human Tenon’s fibroblasts were exposed to transforming growth factor-β1 (TGF-β1) for up to 48 hours with or without siRNAs targeting Hsp47. The densitometric data are expressed as the mean ± S.E.M. (n = 16 for each group) *p < 0.001.

Similar articles

Cited by

References

    1. Skuta GL, Parrish RK 2nd. Wound healing in glaucoma filtering surgery. Surv Ophthalmol. 1987;32:149–170. doi: 10.1016/0039-6257(87)90091-9. - DOI - PubMed
    1. Cordeiro MF, Bhattacharya SS, Schultz GS, Khaw PT. TGF-beta1, -beta2, and -beta3 in vitro: biphasic effects on Tenon's fibroblast contraction, proliferation, and migration. Invest Ophthalmol Vis Sci. 2000;41:756–763. - PubMed
    1. Meyer-Ter-Vehn T, Grehn F, Schlunck G. Localization of TGF-beta type II receptor and ED-A fibronectin in normal conjunctiva and failed filtering blebs. Mol Vis. 2008;14:136–141. - PMC - PubMed
    1. Saika S, Yamanaka O, Sumioka T. et al.Fibrotic disorders in the eye: targets of gene therapy. Prog Retin Eye Res. 2008;27:177–196. doi: 10.1016/j.preteyeres.2007.12.002. - DOI - PubMed
    1. Seong GJ, Hong S, Jung SA. et al.TGF-beta-induced interleukin-6 participates in transdifferentiation of human Tenon's fibroblasts to myofibroblasts. Mol Vis. 2009;15:2123–2128. - PMC - PubMed

Publication types